A股午評：三大指數齊升 北上資金淨買入近60億元 大金融、汽車汽配等板塊升幅居前
重磅信號！匯金公司出手增持四大行；A股主要指數齊升，截至午間收盤，滬指升0.83%報3104點；深證成指升0.69%，創業板指升0.74%。兩市超2900股上升，半日成交5392億元，北上資金淨買入59.96億元。
盤面上，減肥藥概念股繼續活躍，百花醫藥2連板；華為概念股繼續活躍，歐菲光領升；大金融板塊走高，銀行、保險及證券股普升，中國太保、瑞豐銀行領升；肝炎概念股拉昇，廣生堂一度升停；汽車汽配股走高，眾泰汽車、隆基機械等多股升停；機器人、中特估、5.5G等板塊升幅居前。另外，半導體板塊走低，冠石科技跌停；遊戲股下挫，愷英網絡跌停；CPO概念走低，華力創通跌約8%；光刻機、油氣及文化傳媒等板塊跌幅居前。
大金融板塊走高，銀行、保險及證券股普升，中國太保、瑞豐銀行領升
A股銀行、保險及證券股普升，中國太保、瑞豐銀行及中國銀河領升。昨晚，農行、中行、建行、工行紛紛公吿，控股股東匯金公司增持其A股股份，且擬在未來6個月繼續增持。以10月11日四大行收盤價估算，匯金公司增持合計約4.77億元。
汽車汽配股持續走高 長城汽車、隆基機械等多股升停
長城汽車、眾泰汽車升停，長安汽車升超7%，中通客車、海馬汽車、江鈴汽車、金龍汽車等升幅居前。隆基機械、光洋股份、模塑科技封板升停，西菱動力衝擊升停，科華控股、萬安科技、鵬翎股份等跟升。消息面上，10月11日，華為與長安合作的新車型阿維塔12在重慶量產下線，即將正式上市交付，今年第四季度，阿維塔12將在中國市場開啟交付。
肝炎概念股拉昇 廣生堂一度20CM升停
百花葯業升停，廣生堂一度20CM升停，熱景生物、雙成藥業、賽隆藥業等跟升。消息面上，美股生物科技公司Tempest股價飆升3972.53%。Tempest是一家臨牀階段腫瘤公司，致力於將腫瘤靶向和免疫介導機制結合起來開發小分子，這類小分子可能具有治療多種腫瘤的潛力。該司研究藥物TPST-1120與羅氏的兩種藥物結合起來使用後，不可切除肝細胞癌患者的無病生存期大幅提高。
遊戲板塊走低 愷英網絡跌停
愷英網絡跌停，盛天網絡、三七互娛、吉比特、電魂網絡、完美世界、迅遊科技等紛紛跟跌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
